Clinical Trial of Vormatrigine in Adult Patients With Epilepsy

Korábbi kezelés

• Participant who plans to enter another interventional investigational study or is on any prohibited medication

Egyéb

• Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor
• Participant who is pregnant, lactating or planning to become pregnant
• Participant who is ineligible for the extension clinical trial in the view of the investigator

• Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program)
• Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor